Oxford BioMedica plc (LON:OXB) was upgraded by investment analysts at N+1 Singer to a “hold” rating in a research note issued on Friday.

Shares of Oxford BioMedica plc (LON:OXB) opened at 3.1053 on Friday. The company’s 50-day moving average price is GBX 3.63 and its 200-day moving average price is GBX 4.63. The company’s market cap is GBX 82.75 million. Oxford BioMedica plc has a 12 month low of GBX 2.98 and a 12 month high of GBX 8.45.

In other Oxford BioMedica plc news, insider Tallarigo ,Lorenzo bought 62,257 shares of Oxford BioMedica plc stock in a transaction on Thursday, August 25th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £2,490.28 ($3,082.03). Also, insider Lorenzo Tallarigo bought 79,988 shares of Oxford BioMedica plc stock in a transaction on Monday, September 26th. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £2,399.64 ($2,969.85).

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/14/oxford-biomedica-plc-oxb-raised-to-hold-at-n1-singer.html

Oxford BioMedica plc Company Profile

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.

Receive News & Ratings for Oxford BioMedica plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica plc and related companies with MarketBeat.com's FREE daily email newsletter.